Tyler Raymond

411 total citations
10 papers, 309 citations indexed

About

Tyler Raymond is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Tyler Raymond has authored 10 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Physiology, 3 papers in Molecular Biology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Tyler Raymond's work include Pain Mechanisms and Treatments (3 papers), Pharmacological Receptor Mechanisms and Effects (3 papers) and Neuropeptides and Animal Physiology (3 papers). Tyler Raymond is often cited by papers focused on Pain Mechanisms and Treatments (3 papers), Pharmacological Receptor Mechanisms and Effects (3 papers) and Neuropeptides and Animal Physiology (3 papers). Tyler Raymond collaborates with scholars based in United States, Singapore and Iran. Tyler Raymond's co-authors include Douglas Maurer, Edward J. Bilsky, John J. Lowery, Jean M. Bidlack, Robin Polt, Denise Giuvelis, Nicholas W. Lukacs, Rosemary Rochford, Cory M. Hogaboam and S L Kunkel and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Life Sciences and Organic & Biomolecular Chemistry.

In The Last Decade

Tyler Raymond

9 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tyler Raymond United States 7 84 82 58 39 36 10 309
Joanna Hill United States 10 54 0.6× 51 0.6× 91 1.6× 22 0.6× 22 0.6× 13 447
Jeffrey N. Schellinger United States 11 43 0.5× 93 1.1× 54 0.9× 133 3.4× 11 0.3× 35 459
Nicole Fischer United States 12 25 0.3× 48 0.6× 49 0.8× 35 0.9× 61 1.7× 26 488
Taoufiq Dakka Morocco 10 98 1.2× 64 0.8× 58 1.0× 61 1.6× 108 3.0× 21 561
Okdeep Kaur United Kingdom 8 75 0.9× 30 0.4× 40 0.7× 145 3.7× 24 0.7× 9 374
Jasmin Ghaemi Kerahrodi Germany 10 15 0.2× 74 0.9× 65 1.1× 54 1.4× 35 1.0× 21 410
Ana I. Maldonado United States 12 19 0.2× 65 0.8× 70 1.2× 44 1.1× 31 0.9× 34 380
Rachel A. Bishop United States 10 66 0.8× 52 0.6× 44 0.8× 15 0.4× 13 0.4× 13 268
Julie A. Jones United Kingdom 9 59 0.7× 114 1.4× 23 0.4× 11 0.3× 51 1.4× 18 383
Ben Thompson United Kingdom 7 65 0.8× 24 0.3× 28 0.5× 28 0.7× 39 1.1× 20 218

Countries citing papers authored by Tyler Raymond

Since Specialization
Citations

This map shows the geographic impact of Tyler Raymond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tyler Raymond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tyler Raymond more than expected).

Fields of papers citing papers by Tyler Raymond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tyler Raymond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tyler Raymond. The network helps show where Tyler Raymond may publish in the future.

Co-authorship network of co-authors of Tyler Raymond

This figure shows the co-authorship network connecting the top 25 collaborators of Tyler Raymond. A scholar is included among the top collaborators of Tyler Raymond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tyler Raymond. Tyler Raymond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Raymond, Tyler. (2023). Chronic Pain Syndromes: Chronic Neuropathic Pain.. PubMed. 533. 27–40. 6 indexed citations
2.
Raymond, Tyler, et al.. (2023). Chronic Asthma Treatment: Common Questions and Answers.. PubMed. 107(4). 358–368.
3.
Schroeder, Jeremy L., et al.. (2022). Is buprenorphine safe for the treatment of chronic pain in adults?. Evidence-Based Practice. 25(9). 18–19. 1 indexed citations
4.
Raymond, Tyler, et al.. (2021). Nonopioid Pharmacologic Treatments for Chronic Pain.. American family physician. 103(9). 561–565. 6 indexed citations
5.
Maurer, Douglas, et al.. (2018). Depression: Screening and Diagnosis.. PubMed. 98(8). 508–515. 120 indexed citations
6.
Raymond, Tyler, et al.. (2013). Recognition and Treatment of Freezing and Nonfreezing Cold Injuries. Current Sports Medicine Reports. 12(2). 125–130. 37 indexed citations
7.
Lowery, John J., Tyler Raymond, Denise Giuvelis, et al.. (2010). In Vivo Characterization of MMP-2200, a Mixed δ/μ Opioid Agonist, in Mice. Journal of Pharmacology and Experimental Therapeutics. 336(3). 767–778. 66 indexed citations
8.
Raymond, Tyler, et al.. (2009). 6β-naltrexol preferentially antagonizes opioid effects on gastrointestinal transit compared to antinociception in mice. Life Sciences. 85(11-12). 413–420. 9 indexed citations
9.
Raymond, Tyler, Matthew Schaller, Cory M. Hogaboam, et al.. (2007). Toll-like Receptors, Notch Ligands, and Cytokines Drive the Chronicity of Lung Inflammation. Proceedings of the American Thoracic Society. 4(8). 635–641. 42 indexed citations
10.
Cheng, Kejun, In Jong Kim, Steven A. Adah, et al.. (2007). Opioid ligands with mixed properties from substituted enantiomeric N-phenethyl-5-phenylmorphans. Synthesis of a µ-agonist δ-antagonist and δ-inverse agonists. Organic & Biomolecular Chemistry. 5(8). 1177–1190. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026